Print this entryWhile there was a lot of initial hype on this IPO 2 years ago demand in the biotech IPO market has waned considerably. Sam Waksal founded the company in 2010 but has recently sold his stake for 25mm. We are hearing of no demand with in the 16-20 range and the large biotech […]